BAN 1503
Alternative Names: AD-1503; BAN-1503; Trunc AbetaLatest Information Update: 05 Feb 2021
At a glance
- Originator BioArctic
- Class Antibodies; Antidementias; Neuroprotectants
- Mechanism of Action Amyloid beta-protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alzheimer's disease